|
|
||||||||
Commentary |
1 Kaiser Permanente Oakland Medical Center, 280 W MacArthur Blvd., Oakland, CA
94611.
2 Kaiser Permanente Santa Rosa Medical Offices, 3559 Round Barn Blvd., Santa
Rosa, CA 95403.
Received June 8, 2004; accepted after revision June 17, 2004.
This article is a commentary on the preceding article by Yun and Lee.
We conducted an adequately powered randomized trial to evaluate potential
therapeutic effects of contrast media in HSG
[6]. Our prospective,
randomized study of 666 infertile women compared reproductive success rates
after HSG with water-soluble and oil-soluble contrast agents. We designed our
study to have a statistical power sufficient to detect a difference between
live birth rates associated with these agents of 20% vs 10%, two thirds the
size of the 30% versus 10% difference detected in the excellent study by
Rasmussen et al. [4]. We did
not detect such a difference. In our study, the differences among the live
birth rates of 20.4% after use of a water-soluble contrast agent, 19.4% after
use of oil-soluble contrast agents (Ethiodol [ethiodized poppy seed oil],
Savage Laboratories), and 21.8% after sequential use of both were not
statistically significant (
2 = 0. 97, p = 0.61).
These reproductive success rates are statistically indistinguishable,
indicating no differences in the fertility-promoting effects of the different
HSG contrast media that we evaluated. Thus, regardless of whether Ethiodol
does or does not have significant immunomodulatory effects, our findings
indicate that it is not associated with increased conception or term pregnancy
rates compared with water-soluble contrast agents. This finding argues
strongly against the authors' interpretation
[1], calling its foundation
into question.
As likely an explanation for increased term pregnancy rates after HSG, if such an effect were real, is not that either oil-based or water-based agents have a causal effect but rather that couples are more intensively trying to become pregnant at the time of HSG studies. Measurement of the time and frequency of intercourse before and after HSG and analysis of the association of reproductive success with intercourse frequency might indicate the extent to which this factor has confounded analyses indicating that HSG has therapeutic effects. To our knowledge, no such randomized, prospective study has been conducted.
Whatever immunologic perturbations may result from HSG, little or no evidence supports the hypothesis that enhanced fertility and term pregnancy rates are related directly to contrast agents of any kind. No statistically significant difference in the term pregnancy rates associated with oil-versus water-soluble contrast agents has been found. The myth of the "therapeutic effect" of HSG should be put aside until it has been convincingly proven to exist.
References
This article has been cited by other articles:
![]() |
N. P. Johnson, W. E. Hadden, L. W. Chamley, D. B. Spring, H. E. Barkan, A. J. Yun, and P. Y. Lee Fertility Enhancement by Hysterosalpingography with Oil-Soluble Contrast Media: Reality Not Myth Am. J. Roentgenol., December 1, 2005; 185(6): 1654 - 1657. [Full Text] [PDF] |
||||
![]() |
A. J. Yun, D. B. Spring, and H. E. Barkan Enhanced Fertility After Diagnostic Hysterosalpingography: The Debate Continues Am. J. Roentgenol., January 1, 2005; 184(1): 347 - 348. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |